Trodelvy

From WikiMD.org
Jump to navigation Jump to search
Trodelvy
TermTrodelvy
Short definitionTrodelvy - (pronounced) (troh-DEL-vee) drug used to treat adults with certain types of urothelial cancer (a type of cancer of the bladder or urinary tract) or breast cancer who have already been treated with other therapies. It is also being studied in the treatment of other types of cancer. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Trodelvy - (pronounced) (troh-DEL-vee) drug used to treat adults with certain types of urothelial cancer (a type of cancer of the bladder or urinary tract) or breast cancer who have already been treated with other therapies. It is also being studied in the treatment of other types of cancer. Trodelvy contains a monoclonal antibody called sacituzumab that attaches to a protein called TROP2, which is found on some cancer cells. It also contains a cancer drug called SN-38, which can help kill cancer cells. Trodelvy is a type of antibody-drug conjugate. Also called sacituzumab govitecan

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski